Indeed, in pancreatic cancer cells FGF1/FGFR1 signaling activates AKT pathway leading to GSK-3β phosphorylation and inhibition which finally results in decreased phosphorylation of c-Myc T58 and in reduced c-Myc proteasomal degradation. This evidence concerns the gene FGFR1 and pancreatic neoplasm.